Elekta (OTCMKTS:EKTAY) Shares Gap Up – Here’s What Happened

Elekta AB (OTCMKTS:EKTAY) gapped up before the market opened on Tuesday . The stock had previously closed at $5.0150, but opened at $5.21. Elekta shares last traded at $5.21, with a volume of 1,007 shares.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Elekta has an average rating of “Hold”.

Elekta Trading Up 2.9%

The company has a debt-to-equity ratio of 0.47, a current ratio of 0.87 and a quick ratio of 0.68. The business’s 50-day moving average is $5.26 and its 200 day moving average is $5.64. The firm has a market capitalization of $1.94 billion, a P/E ratio of -43.83 and a beta of 1.05.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings data on Thursday, August 27th. The company reported $0.07 earnings per share (EPS) for the quarter. Elekta had a negative net margin of 2.38% and a positive return on equity of 13.31%. The firm had revenue of $372.30 million during the quarter. As a group, analysts anticipate that Elekta AB will post 0.43 EPS for the current fiscal year.

About Elekta

Elekta AB is a Sweden-based medical technology company focused on radiation oncology and precision treatment solutions. The company develops and supplies systems used to diagnose, plan and deliver treatments for cancer and other conditions affecting the brain and nervous system.

Its product portfolio includes linear accelerators for external-beam radiotherapy, stereotactic radiosurgery systems such as Leksell Gamma Knife, brachytherapy equipment and treatment-planning, oncology information and workflow software.